Deborah L. Cadena Ph.D.

Dr. Debbie Cadena focuses her practice on life sciences and biotechnology patent prosecution. She has more than a decade of experience in all aspects of patent prosecution, including drafting and prosecuting U.S. and non-U.S. patent applications, managing patent portfolios, and evaluating competitive technologies.

Debbie frequently counsels clients on strategies for formulating and implementing intellectual property portfolios that optimize business objectives. She is a former post-doctoral fellow and research faculty member in the School of Medicine at the University of California, San Diego and has extensive scientific experience in the areas of biochemistry, molecular biology, and cell biology. Debbie has assisted clients in the realization of patent portfolios in such diverse technology areas as immunology (including vaccines and antibody therapeutics), genomics, proteomics, systems biology, small molecules, medicinal chemistry, peptide and protein chemistry, drug screening, in vivo and ex vivo therapeutics (including production and formulation of biologics, gene therapy, and stem cell therapy), transgenic animals, nutraceuticals, and bioinformatics. [1]